Last reviewed · How we verify
NCT04389476
The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes
trial testing Standardized crisis management and coping protocol plan toward Coronavirus disease 2019 (COVID-19) in The Psychological Impact of COVID-19 in 2,500 participants. Status unknown.
31 July 2023
Quick facts
| Lead sponsor | Kaohsiung Kai-Suan Psychiatric Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,500 |
| Start date | 15 June 2020 |
| Primary completion | 31 July 2023 |
| Estimated completion | 31 July 2023 |
Drugs / interventions tested
- Standardized crisis management and coping protocol plan toward Coronavirus disease 2019 (COVID-19)
Conditions studied
- The Psychological Impact of COVID-19 — all drugs for The Psychological Impact of COVID-19 →
Sponsor
Kaohsiung Kai-Suan Psychiatric Hospital
Who can join
20 and older, any sex, with The Psychological Impact of COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Coronavirus disease 2019 (COVID-19) had its outbreak in late 2019 in China and is considered a biological disaster. With medical organizations and staff on the frontline, the investigators should conduct assessments, for the different tiers of medical staff, patients, and community residents, on the short- term psychological and mental disabilities or danger factors that they might have faced. As such, the investigators can design and establish a set of evaluative indicators of the risks of biological disasters, and strategies to manage guide and cope, and internal/ external testing strategies. These work in guaranteeing quality and performance, and as such, establishing "Digital Platform for Integrated Research of Coronavirus disease 2019 (COVID-19)".
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
Pollock A, Campbell P, Cheyne J, Cowie J, et al · · 2020 · cited 412× · PMID 33150970 · DOI 10.1002/14651858.cd013779 -
Relationship of Societal Adaptation with Vaccine Worries among Healthcare Workers during the COVID-19 Pandemic: The Mediating Effects of Posttraumatic Stress Disorder.
Hsieh KY, Li DJ, Chou FH, Hsu ST, et al · · 2022 · cited 8× · PMID 35954849 · DOI 10.3390/ijerph19159498
Verify or expand the search:
- PubMed search for NCT04389476
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Kaohsiung Kai-Suan Psychiatric Hospital trials
Trials by the same sponsor.
- NCT04426565 — The Follow-up Study for the Patients of Illicit Substance Use Disorder · NA · unknown
- NCT04093960 — Escitalopram Plus PS128 vs. Escitalopram · Phase 4 · terminated
- NCT04181567 — Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04389476 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kaohsiung Kai-Suan Psychiatric Hospital
- Last refreshed: 16 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04389476.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing